[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
[ Wed, Nov 29th 2023 ]: WOPRAI
Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $26 on, Nov 29th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $29 to $26 on, Nov 29th, 2023.
Kevin has made no other calls on CCRN in the last 4 months.
There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, all agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $21 on, Friday, November 3rd, 2023
- Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $22 on, Friday, November 3rd, 2023
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023